<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background: The Severe <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:hpo ids='HP_0001875'>Neutropenia</z:hpo> International Registry (SCNIR) was organized 10 years ago to improve understanding and treatment of the group of rare <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> causing blood neutrophil counts to be &lt; 500/muL for months or years </plain></SENT>
<SENT sid="1" pm="."><plain>Patients and Methods: Patients now enrolled include those with severe <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> (n = 526), cyclic <z:hpo ids='HP_0001875'>neutropenia</z:hpo> (n = 205), idiopathic <z:hpo ids='HP_0001875'>neutropenia</z:hpo> (n = 349), <z:hpo ids='HP_0001904'>autoimmune neutropenia</z:hpo> (n = 68), and other (n = 15) </plain></SENT>
<SENT sid="2" pm="."><plain>More than 90% (1053 of 1163) of patients in the SCNIR have been treated with granulocyte colony-stimulating factor (G-CSF), median dose 3.33 mug/kg per day </plain></SENT>
<SENT sid="3" pm="."><plain>Results: Granulocyte colony-stimulating factor has reduced the occurrence of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, hospitalization, and antibiotics and improved patients' quality of life </plain></SENT>
<SENT sid="4" pm="."><plain>Most patients have noted few adverse effects with G-CSF treatment </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000939'>Osteoporosis</z:hpo>/<z:hpo ids='HP_0000938'>osteopenia</z:hpo> has been reported in 14% of <z:hpo ids='HP_0000001'>all</z:hpo> patients, and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo> have occurred in 57 patients, including severe <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> (11.8%; 50 of 422), <z:e sem="disease" ids="C0272170" disease_type="Disease or Syndrome" abbrv="">Shwachman-Diamond syndrome</z:e> (8.1%; 3 of 37), and 4 others </plain></SENT>
<SENT sid="6" pm="."><plain>The SCNIR is an important resource for studies on the genetic and molecular basis for the disorders causing <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001875'>neutropenia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Conclusion: The findings of mutations in the gene for neutrophil elastase as causing cyclic and <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo>, the role of mutations in the gene for the G-CSF receptor in the evolution of severe <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> to <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo>, and the importance of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> as the cellular mechanism for several diseases causing severe <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001875'>neutropenia</z:hpo> have come from studies on these patients </plain></SENT>
</text></document>